Trypanosoma vivax GM6 Antigen: A Candidate Antigen for Diagnosis of African Animal Trypanosomosis in Cattle-Reference-Cited by-同舟云学术

Trypanosoma vivax GM6 Antigen: A Candidate Antigen for Diagnosis of African Animal Trypanosomosis in Cattle

Published:2013-10-25 Issue:10 Volume:8 Page:e78565
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pillay Davita,Izotte Julien,Fikru Regassa,Büscher Philipe,Mucache Hermogenes,Neves Luis,Boulangé Alain,Seck Momar Talla,Bouyer Jérémy,Napier Grant B.,Chevtzoff Cyrille,Coustou Virginie,Baltz Théo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research;PM Kristjanson;Agric Syst,1999

2. Pathogenic mechanisms of Trypanosoma evansi infections;N Habila;Res Vet Sci,2012

3. Widespread occurrence of Trypanosoma vivax in bovines of tsetse- as well as non-tsetse-infested regions of Ethiopia: A reason for concern?;R Fikru;Vet Parasitol,2012

4. Trypanosoma (Duttonella) vivax: its biology, epidemiology, pathogenesis, and introduction in the New World - a review;AL Osório;Mem Inst Oswaldo Cruz,2008

5. Pathogenesis of African Trypanosomiasis,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Domestic dogs as reservoirs for African trypanosomiasis in Mambwe district, eastern Zambia;Scientific Reports;2024-09-10

2. Improved serodiagnosis of Trypanosoma vivax infections in cattle reveals high infection rates in the livestock regions of Argentina;PLOS Neglected Tropical Diseases;2024-06-26

3. Improved Serodiagnosis ofTrypanosoma vivaxInfections in Cattle Reveals Higher Infection Rates in the Livestock Regions of Argentina;2024-02-23

4. Trypanosome Infections and Anemia in Cattle Returning from Transhumance in Tsetse-Infested Areas of Cameroon;Microorganisms;2023-03-09

5. Methods Applied to the Diagnosis of Cattle Trypanosoma vivax Infection: An Overview of the Current State of the Art;Current Pharmaceutical Biotechnology;2023-03